Floyd Benjamin Named CEO of Pharmaceutical Company, Akorn Inc

March 1999
Jet;03/22/99, Vol. 95 Issue 16, p17
Advises that Floyd Benjamin Sr. has been promoted to the post of chief executive officer of Akorn Inc. in Chicago, Illinois. The appointment which makes him the only black chief officer of a pharmaceutical company in the United States; His technical and managerial experience; Education.


Related Articles

  • Changing places. Plagakis, Jim // Drug Topics;5/17/99, Vol. 143 Issue 9, p46 

    Presents views on the role of chief executive officers (CEO) in a pharmaceutical company. Importance of pharmacists; Concern of a CEO.

  • Who's who in pharmaceutical industry.  // Economic Review (05318955);Aug96, Vol. 27 Issue 8, p33 

    Profiles three prominent chief executives of pharmaceutical companies in Pakistan. Brookes Pharmaceutical Labs president A. Haseeb Khan; Glaxo Wellcome Pakistan managing director Nighat Parveen; Highnoon Laboratories Ltd. chief executive Jawaid Tariq Khan.

  • DOCTORS' ORDERS. Michels, A.J. // Fortune;6/15/1992, Vol. 125 Issue 12, p13 

    Describes various health practices among chief executive officers (CEO) that head pharmaceutical companies. Options for exercise; Dietary considerations; Comments from Amgen CEO Gordon Binder; Theodore Cooper of Upjohn; John Stafford of American Home Products.

  • REGIONAL REPORT: TRIANGLE.  // Business North Carolina;Nov2004, Vol. 24 Issue 11, p12 

    Presents news briefs on business and industries in the triangle region of North Carolina as of November 2004. Key reason for the replacement of bioMerieux CEO Philippe Sans with Eric Bouvet; Recruitment of Charles Peters Jr. at Red Hat; Decision of the state Division of Facility Services to the...

  • Start anywhere, ask questions and fail early. Arnold, Matthew // Medical Marketing & Media;May2010, Vol. 45 Issue 5, p28 

    The article presents the insights of chief executive officers (CEOs) on the future of the pharmaceutical industry in the U.S.

  • Former Geneva head to lead B2B health exchange.  // Drug Store News;8/14/2000, Vol. 22 Issue 11, p6 

    Announces that David Hurley has been named chief executive officer of a business-to-business health exchange formed by four drug distributors in the United States. Responsibilities of Hurley; Information on the company.

  • The Management Behind the Molecules. Van Arnum, Patricia // Chemical Market Reporter;3/17/2003, Vol. 263 Issue 11, pFR11 

    Focuses on key revenue drivers outlined by chief executive officers in pharmaceutical industry. Financial performance in 2002; Projected transition in 2003 in terms of new drug development and product launches; Key therapeutic areas.

  • CEO: 'We needed to look at our Rx business'.  // Chain Drug Review;4/25/2011, Vol. 33 Issue 8, p181 

    The article reports on the statements of drugstore.com Inc. chairman and chief executive officer (CEO) Dawn Lepore regarding the need to look at their drug business.

  • Hassan Joins S-P.  // Pharmaceutical Executive;May2003, Vol. 23 Issue 5, p26 

    Reports on the departure of chief executive officer Fred Hassan from Pharmacia in the U.S. Administration of Schering-Plough; Financial crisis at the pharmaceutical company; Executive challenges with governmental inquiry regarding accounting matters and marketing claims.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics